Ensuring the development of stable probiotic finished products based on biocompatibility.
VAKYA PROB relentlessly looks for insights and developments to lead us to innovative probiotic solutions that have a healthy impact. In our endeavour to innovate, we consistently improve, expand our product gamut and keep with the dynamic needs of consumers.
Our in-house R&D centre comprises of qualified researchers committed to expanding our repository of probiotic strains by isolating new strains that add to our vast cell bank collection which boasts of 500 plus well-characterized strains.
From the selection of probiotic strains to initial production at small scale laboratory fermenters to production at the pilot plant, R & D is behind every stage to ensure safe and robust implementation.
It ensures the development of stable probiotic finished products based on biocompatibility with different ingredients and excipients.
It is also engaged in the development of new technologies and delivery forms to offer complete protection and maintain the viability of the probiotic strains when its survivability is questioned, especially in food applications. We create professional synergies with experts in clinical research at hospitals, research institutions, and universities to conduct clinical trials and document the safety and efficacy of our products.
- Type-2 Diabetes mellitus
- Insulin sensitivity
- serum lipid profiles
- pro-inflammatory cytokines
- gut microbial populations in adults
- Acute diarrhoea in children and adults
- Constipation in adults
- Irritable bowel syndrome in children & adults
- Inflammatory bowel disease in adults
- Functional abdominal pain in children
- Dental caries
- For upper respiratory tract infections in children
- Bacterial vaginosis
- Poly cystic ovarian syndrome
- Urinary tract infections
- Muscle Building
- Essential Amino Acids
- High Biological Value